{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA LDT Rule Begins Enforcement Discretion Phaseout, But Some Discretion Remains",
"url": "https://www.lexblog.com/2024/05/21/fda-ldt-rule-begins-enforcement-discretion-phaseout-but-some-discretion-remains/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-Q45JBNEE",
"url": "https://www.lexblog.com/lib/Q45JBNEE/"
},
"datePublished": "2024-05-21T11:30:26-04:00",
"dateModified": "2024-05-21T08:31:22-04:00",
"author": {
"@type": "Person",
"name": "Rebecca Jones McKnight, Kevin Madagan, Sarah Thompson Schick, Akosua Tuffuor"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Reed Smith LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Health Industry Washington Watch",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=26302",
"sourceStability": "may-move"
}